How ConsumerAffairs uses cookies

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link:

We're there for consumers when it counts — with the right information, right on time.

Donate to our work

Kristen Dalli

Independent journalism since 1998

Kyle James

70,000+ consumer news stories published

Mark Huffman

Your support helps us invest in our mission to empower consumers to make informed decisions.

ConsumerAffairs is a for-profit company. Your contribution is not tax deductible.

Study links GLP-1, other diabetes drugs to lower risk of Alzheimer’s and dementia

The new study could potentially pave the way for new strategies to prevent dementia using drugs that are already approved and on the market.

The new study could pave the way for new strategies to prevent dementia using drugs already on the market.


Stay informed

Sign up for The Daily Consumer

Get the latest on recalls, scams, lawsuits, and more

    By entering your email, you agree to sign up for consumer news, tips and giveaways from ConsumerAffairs. Unsubscribe at any time.

    Thanks for subscribing.

    You have successfully subscribed to our newsletter! Enjoy reading our tips and recommendations.

    Was this article helpful?

    Share your experience about ConsumerAffairs

    Was this article helpful?

    Share your experience about ConsumerAffairs